Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Disease Progression × RNA-Seq × Clear all

Status

Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Sarcoma 1 Disease Progression 1

Interventions

Nivolumab 2 venetoclax 1 tivozanib 1 pembrolizumab 1 niraparib 1 ibrutinib 1 encorafenib 1 durvalumab 1 copanlisib 1 capivasertib 1 RNA-Seq 1 Oxaliplatin 1 Leucovorin 1 Interleukin-2 1 Gemtuzumab 1 Gemcitabine 1 Fulvestrant 1 Folfox protocol 1 Fluorouracil 1 Cisplatin 1 Cetuximab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06751251 2025-07-10

The Exploration of OX40 (CD134) Expression Levels in Sarcoma Specimens and Its Clinical Application in Prognosis Determination

Peking University People's Hospital

Active not recruiting

Sarcoma, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon ⚡